Acelyrin, Inc. (SLRN)

USD 3.27

(-6.57%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021
Revenue - - -
Cost of Revenue 115 Thousand - -
Gross Profit -115 Thousand - -
Operating Expenses 422.06 Million 254.68 Million 41.79 Million
Selling, General and Administrative Expenses 66.17 Million 24.05 Million 3.56 Million
Research and Development Expenses 355.88 Million 230.62 Million 38.23 Million
Other Expenses - -132 Thousand -45 Thousand
Cost and Expenses 422.06 Million 254.68 Million 41.79 Million
Operating Income -422.06 Million -254.68 Million -41.79 Million
Interest Expense - - -
Income Tax Expense - -4.17 Million -41.79 Thousand
Earnings before Tax -381.64 Million -250.46 Million -41.83 Million
Net Income -381.64 Million -250.46 Million -41.83 Million
Earnings Per Share Basic -5.43 -12.25 -2.05
Earnings Per Share Diluted -5.43 -12.25 -2.05
Weighted Average Shares Outstanding 70.24 Million 20.44 Million 20.44 Million
Weighted Average Shares Outstanding (Diluted) 70.24 Million 20.44 Million 20.44 Million
Gross Margin - - -
EBIT Margin - - -
Profit Margin - - -
EBITDA -381.52 Million -64.77 Million -41.83 Million
Earnings Before Tax Margin - - -

Income Statement Charts